Anti-inflammatory Effect of Juniperus Procera Extract in Rats Exposed to Streptozotocin Toxicity

Author(s): Adel Qlayel Alkhedaide*

Journal Name: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
(Formerly Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents)

Volume 18 , Issue 1 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: Chronic inflammation is a critical health issue and implicated in several chronic health problems such as tumors, auto-immune disorder, hypertension or diabetes. However, Juniperus procera is one of the famous ancient plants that has been traditionally used to treat several diseases such as hyperglycemia, hepatitis, jaundice, bronchitis, and pneumonia.

Objective: Current study is an attempt to investigate the anti-inflammatory effect of Juniperus procera extract on rats exposed to cytotoxicity caused experimentally by streptozotocin injections.

Methods: Five groups of adult Wistar rats (10 rats each) were examined as (Normal control, Normal rats treated with Juniperus procera extract, rats administrated with streptozotocin, rats administrated with streptozotocin and treated with insulin and, rats administrated with streptozotocin and Juniperus procera extract). At the end of the experiment, blood was collected from experimented rats. Animals then were killed and small parts of both pancreas and liver were collected for gene expression and histopathological examination.

Results: Serum analysis showed a significant increase in glucose, IL-6, IL-2 and TNF-α levels in rats exposed to streptozotocin. That change was reduced in rats cotreated with insulin or Juniperus procera extract. Moreover, streptozotocin showed a significant upregulation of IL-6, TNF-α and A2M genes, while, either insulin or Juniperus procera treatment was restored to normal status. Streptozotocin induced inflammation within hepatic tissues which clearly reduced in hepatic tissues of both insulin and junipers cotreated groups.

Conclusion: Streptozotocin toxicity induces acute inflammation and increases serum glucose, IL-6, IL-2 and TNF-α levels. However, Juniperus procera extract was found to significantly prevent that reaction within four weeks experimented frame time.

Keywords: Anti-inflammatory, IL-2, IL-6, Juniperus procera, streptozotocin, TNF-α, α2 microglobulin.

[1]
Schmid-Schonbein, G.W. Analysis of inflammation. Annu. Rev. Biomed. Eng., 2006, 8, 93-131.
[2]
A current view on inflammation. Nat. Immunol., 2017, 18(8), 825.
[3]
Zhang, J.M. An, J. Cytokines, inflammation, and pain. Int. Anesthesiol. Clin., 2007, 45(2), 27-37.
[4]
Dinarello, C.A. Proinflammatory cytokines. Chest, 2000, 118(2), 503-508.
[5]
Navarro, J.F.; Mora, C. Diabetes, inflammation, proinflammatory cytokines, and diabetic nephropathy. Sci. World J., 2006, 6, 908-917.
[6]
Alexandraki, K.; Piperi, C.; Kalofoutis, C.; Singh, J.; Alaveras, A.; Kalofoutis, A. Inflammatory process in type 2 diabetes: The role of cytokines. Ann. N. Y. Acad. Sci., 2006, 1084, 89-117.
[7]
Navarro-Gonzalez, J.F.; Jarque, A.; Muros, M.; Mora, C.; Garcia, J. Tumor necrosis factor-alpha as a therapeutic target for diabetic nephropathy. Cytokine Growth Factor Rev., 2009, 20(2), 165-173.
[8]
Kristiansen, O.P.; Mandrup-Poulsen, T. Interleukin-6 and diabetes: The good, the bad, or the indifferent? Diabetes, 2005, 54(Suppl. 2), S114-S124.
[9]
Burits, M.; Asres, K.; Bucar, F. The antioxidant activity of the essential oils of Artemisia afra, Artemisia abyssinica and Juniperus procera. Phytother. Res., 2001, 15(2), 103-108.
[10]
Al-Attar, A.M.; Alrobai, A.A.; Almalki, D.A. Effect of Olea oleaster and Juniperus procera leaves extracts on thioacetamide induced hepatic cirrhosis in male albino mice. Saudi J. Biol. Sci., 2016, 23, 363-371.
[11]
Alqasoumi, S.I.; Abdel-Kader, M.S. Terpenoids from Juniperus procera with hepatoprotective activity. Pak. J. Pharm. Sci., 2012, 25(2), 315-322.
[12]
Loizzo, M.R.; Tundis, R.; Conforti, F.; Saab, A.M.; Statti, G.A.; Menichini, F. Comparative chemical composition, antioxidant and hypoglycaemic activities of Juniperus oxycedrus ssp. oxycedrus L. berry and wood oils from Lebanon. Food Chem., 2007, 105(2), 572-578.
[13]
Alkhedaide, A.Q. Preventive effect of Juniperus procera extract on liver injury induced by lithocholic acid. Cell. Mol. Biol. (Noisy-le-grand), 2018, 64(13), 63-68.
[14]
Cheng, D.; Liang, B. Li, Y. Antihyperglycemic effect of Ginkgo biloba extract in streptozotocin-induced diabetes in rats. BioMed Res. Int., 2013, 2013, 1-7.
[15]
Ismail, T.A.; Nassan, M.A.; Alkhedaide, A.Q.; Soliman, M.M. Modulation of aquaporins expressions and its impact on alleviating diabetic complications in rats: Role of Citrullus colocynthis. Natl. J. Physiol. Pharm. Pharmacol., 2016, 6(4), 310.
[16]
Burits, M.; Asres, K.; Bucar, F. The antioxidant activity of the essential oils of Artemisia afra, Artemisia abyssinica and Juniperus procera. Phytother. Res., 2001, 15(2), 103-108.
[17]
Al-Attar, A.M.; Alrobai, A.A.; Almalki, D.A. Protective effect of olive and juniper leaves extracts on nephrotoxicity induced by thioacetamide in male mice. Saudi J. Biol. Sci., 2017, 24(1), 15-22.
[18]
Mayeux, R.; Lee, J.; Romas, S.; Mayo, D.; Santana, V.; Williamson, J. Chromosome-12 mapping of late-onset Alzheimer disease among Caribbean Hispanics. Am. J. Hum. Genet., 2002, 70(1), 237-243.
[19]
Christensen, U.; Sottrup-Jensen, L. Mechanism of. alpha. 2-macroglobulin-proteinase interactions. Studies with trypsin and plasmin. Biochemistry, 1984, 23(26), 6619-6626.
[20]
Grinnell, F.; Zhu, M.; Parks, W.C. Collagenase-1 complexes with α2-macroglobulin in the acute and chronic wound environments. J. Invest. Dermatol., 1998, 110(5), 771-776.
[21]
Cvirn, G.; Gallistl, S.; Koestenberger, M.; Kutschera, J.; Leschnik, B.; Muntean, W. Alpha 2-macroglobulin enhances prothrombin activation and thrombin potential by inhibiting the anticoagulant protein C/protein S system in cord and adult plasma. Thromb. Res., 2002, 105(5), 433-439.
[22]
Borth, W.; Luger, T. Identification of alpha 2-macroglobulin as a cytokine binding plasma protein. Binding of interleukin-1 beta to “F” alpha 2-macroglobulin. J. Biol. Chem., 1989, 264(10), 5818-5825.
[23]
Matsuda, T.; Hirano, T.; Nagasawa, S.; Kishimoto, T. Identification of alpha 2-macroglobulin as a carrier protein for IL-6. J. Immunol., 1989, 142(1), 148-152.
[24]
Crookston, K.P.; Webb, D.J.; Wolf, B.B.; Gonias, S.L. Classification of alpha 2-macroglobulin-cytokine interactions based on affinity of noncovalent association in solution under apparent equilibrium conditions. J. Biol. Chem., 1994, 269(2), 1533-1540.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 18
ISSUE: 1
Year: 2019
Page: [71 - 79]
Pages: 9
DOI: 10.2174/1871523018666181126124336

Article Metrics

PDF: 65
HTML: 2